A Study of ABT-888 in Combination With Carboplatin and Gemcitabine in Subjects With Advanced Solid Tumors

NCT01063816 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

79

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumors

Interventions

DRUG: veliparib (ABT-888)
DRUG: carboplatin
DRUG: gemcitabine

Sponsor

AbbVie (prior sponsor, Abbott)